Bleomycin is an oncological medication used to treat a wide range of cancers, such as Hodgkin's lymphoma, testicular ovarian, and cervical cancer. Bleomycin suppliers market the drug in the form of powder for injectable solutions.
Following approval by the FDA in 1973, the earliest bleomycin manufacturer was Bristol-Myers Squibb. As of now, the drug has become included by the WHO in its list of Essential Medicines, which is made up of the safest and most effective drugs recommended for a health system. What is more, current bleomycin manufacturers and suppliers include such well-known pharmaceutical companies as Baxter, Sanofi-Aventis, Pfizer, Hikma, Teva, Mylan, and Hospira.
Bleomycin suppliers and distributors market both generic and trade name formulations of the drug. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified bleomycin manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform.
The retail prices per 15,000 IU bleomycin powder for injectable solution fall into an approximate range of 30,00 EUR to 40,00 EUR.